- Current report filing (8-K)
August 03 2012 - 4:27PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): August 1, 2012
INTERNATIONAL
STEM CELL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-51891
|
|
20-4494098
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification Number)
|
5950 Priestly Drive, Carlsbad, California 92008
(Address of principal executive offices, including zip code)
(760) 940-6383
(Registrants telephone number, including area code)
(Former name
or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CAR 240.13e-4(c))
|
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN
OFFICERS; COMPENSATION ARRANGEMENTS OF CERTAIN OFFICERS
On August 1, 2012, Jeffrey Janus, a director and Senior Vice President,
Operations of International Stem Cell Corporation (the Company), resigned from the Companys Board of Directors. He will continue to be an employee of the Company in his current capacity.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
International Stem Cell Corporation
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Linh Nguyen
|
|
|
|
|
|
|
Linh Nguyen
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
Dated: August 3, 2012
|
|
|
|
|
|
|
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Sep 2024 to Oct 2024
International Stem Cell (QB) (USOTC:ISCO)
Historical Stock Chart
From Oct 2023 to Oct 2024